Evidence map›Paper›PMID 28651541›Full record

ArticleJournal of nanobiotechnology2017

The agglomeration state of nanoparticles can influence the mechanism of their cellular internalisation.

Blanka Halamoda-Kenzaoui, Mara Ceridono, Patricia Urbán, Alessia Bogni, Jessica Ponti, Sabrina Gioria, Agnieszka Kinsner-Ovaskainen

Open access · goldAbstract read
In one paragraph

Article in Journal of nanobiotechnology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 119 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Nanotherapeutic Heterogeneity: Sources, Effects, and Solutions.Small (Weinheim an der Bergstrasse, Germany) · 2024
    Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Blanka Halamoda-KenzaouiEuropean Commission Joint Research Centre, Directorate for Health, Consumers and Reference Materials, Via E. Fermi 2749, TP 127, 21027, Ispra, VA, Italy.
Mara CeridonoEuropean Commission Joint Research Centre, Directorate for Health, Consumers and Reference Materials, Via E. Fermi 2749, TP 127, 21027, Ispra, VA, Italy.
Patricia UrbánEuropean Commission Joint Research Centre, Directorate for Health, Consumers and Reference Materials, Via E. Fermi 2749, TP 127, 21027, Ispra, VA, Italy.
Alessia BogniEuropean Commission Joint Research Centre, Directorate for Health, Consumers and Reference Materials, Via E. Fermi 2749, TP 127, 21027, Ispra, VA, Italy.
Jessica PontiEuropean Commission Joint Research Centre, Directorate for Health, Consumers and Reference Materials, Via E. Fermi 2749, TP 127, 21027, Ispra, VA, Italy.
Sabrina GioriaEuropean Commission Joint Research Centre, Directorate for Health, Consumers and Reference Materials, Via E. Fermi 2749, TP 127, 21027, Ispra, VA, Italy.
Agnieszka Kinsner-OvaskainenEuropean Commission Joint Research Centre, Directorate for Health, Consumers and Reference Materials, Via E. Fermi 2749, TP 127, 21027, Ispra, VA, Italy. agnieszka.kinsner-ovaskainen@ec.europa.eu.ORCID http://orcid.org/0000-0001-9552-5560
Joint Research Centre · ITEuropean Commission · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSignificant progress of nanotechnology, including in particular biomedical and pharmaceutical applications, has resulted in a high number of studies describing the biological effects of nanomaterials. Moreover, a determination of so-called "critical quality attributes", that is specific physicochemical properties of nanomaterials triggering the observed biological response, has been recognised as crucial for the evaluation and design of novel safe and efficacious therapeutics. In the context of in vitro studies, a thorough physicochemical characterisation of nanoparticles (NPs), also in the biological medium, is necessary to allow a correlation with a cellular response. Following this concept, we examined whether the main and frequently reported characteristics of NPs such as size and the agglomeration state can influence the level and the mechanism of NP cellular internalization.

resultsWe employed fluorescently-labelled 30 and 80 nm silicon dioxide NPs, both in agglomerated and non-agglomerated form. Using flow cytometry, transmission electron microscopy, the inhibitors of endocytosis and gene silencing we determined the most probable routes of cellular uptake for each form of tested silica NPs. We observed differences in cellular uptake depending on the size and the agglomeration state of NPs. Caveolae-mediated endocytosis was implicated particularly in the internalisation of well dispersed silica NPs but with an increase of the agglomeration state of NPs a combination of endocytic pathways with a predominant role of macropinocytosis was noted.

conclusionsWe demonstrated that the agglomeration state of NPs is an important factor influencing the level of cell uptake and the mechanism of endocytosis of silica NPs.

Indexed as

EndocytosisCaco-2 CellsDimerizationHumansMicroscopy, Electron, TransmissionNanoparticlesParticle SizeSilicon DioxideSilicon DioxideAgglomeration/aggregationCell uptakeEndocytosis routeIn vitroSilica nanoparticles

Identifiers

PMID28651541
PMCPMC5485545
OpenAlexW2713042294

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.